Search clinical trials for: AMT-101 (oral)-Dose B
Total 1819 results
-
Applied Molecular TransportCompletedPouchitisUnited States, Canada, France, Spain, United Kingdom, Germany, Belgium, Hungary, Netherlands, Switzerland
-
Applied Molecular TransportActive, not recruitingUlcerative ColitisUnited States, Hungary, Ukraine, Germany, United Kingdom, Belarus, Bulgaria, Canada, France, Georgia, Moldova, Republic of, Poland, Russian Federation, Switzerland
-
IntegoGen, LLCWithdrawnHidradenitis SuppurativaUnited States
-
Applied Molecular TransportCompletedUlcerative ColitisGeorgia, Netherlands, Poland, Ukraine
-
Emerald Health PharmaceuticalsCompleted
-
Apollomics Inc.RecruitingGastric Cancer | Pancreatic Cancer | NSCLC | Lung Cancer | Brain Tumor | Glioblastoma Multiforme | Advanced Cancer | Colon Cancer | Solid Tumors | Thyroid Cancer | Renal Cancer | Gastroesophageal Junction Adenocarcinoma | EGFR Gene Mutation | MET Amplification | HGF | MET Alteration | MET Fusion | Exon 14 SkippingUnited States, Spain, France, United Kingdom, Taiwan, Australia, Finland, Italy, Singapore, Hungary, Canada, Puerto Rico, Russian Federation
-
PfizerCompletedFungal InfectionNetherlands
-
Marijn Lijffijt, PhDMichael E. DeBakey VA Medical Center; VistaGen Therapeutics, Inc.Completed
-
University of Wisconsin, MadisonNational Institute of Allergy and Infectious Diseases (NIAID)CompletedClostridium Difficile Infection RecurrenceUnited States
-
PfizerCompletedHepatic ImpairmentUnited States
-
VaxartCompletedSeasonal Influenza BNew Zealand
-
Hookipa Biotech GmbHCentre for Vaccinology Ghent - CEVACCompletedCytomegalovirus InfectionBelgium
-
Chinook Therapeutics, Inc.Active, not recruitingIgA NephropathyKorea, Republic of, United States, United Kingdom
-
Applied Molecular TransportCompletedUlcerative ColitisGermany, Georgia, Moldova, Republic of, Ukraine
-
University of Wisconsin, MadisonAgency for Healthcare Research and Quality (AHRQ)CompletedClostridium Difficile Infection | CDI | C.Difficile DiarrheaUnited States
-
Federal University of Health Science of Porto AlegreNot yet recruitingFungal Infection | Immunosuppression | AIDS and Infections | Disseminated Histoplasma Capsulatum InfectionBrazil
-
Amytrx Therapeutics, Inc.Amarex Clinical ResearchCompletedAtopic DermatitisUnited States
-
Idorsia Pharmaceuticals Ltd.Terminated
-
Taiho Oncology, Inc.CompletedAdvanced Solid TumorsUnited States
-
Curevo IncGreen Cross Corporation; Mogam Biotechnology Research InstituteActive, not recruitingHerpes Zoster | ShinglesUnited States
-
Alessandro PasqualottoHospital de Clinicas de Porto Alegre; Irmandade Santa Casa de Misericórdia... and other collaboratorsCompletedAIDS | HistoplasmosisBrazil
-
Anbogen Therapeutics, Inc.RecruitingNon Small Cell Lung Cancer | Advanced Solid Tumor | HER2 MutationsTaiwan
-
Ornovi, Inc.Withdrawn
-
Idorsia Pharmaceuticals Ltd.CompletedSafety, Tolerability, Pharmacokinetics and PharmacodynamicsFrance
-
PfizerCompletedColitis, UlcerativeSpain, Belgium, Germany, Czech Republic, Norway, Denmark, Slovakia
-
Midnight Pharma, LLCCompletedChronic Primary InsomniaUnited States
-
Ariston Pharmaceuticals, Inc.UnknownMigraine | Migraine Disorders | Migraine Headache | Migraine Without Aura | Migraine With AuraFinland, Netherlands, United Kingdom
-
F2G Biotech GmbHSimbecRresearch Ltd.CompletedInvasive AspergillosisUnited Kingdom
-
Centrexion TherapeuticsCompletedSafety, Tolerability & Pharmacokinetics Study of CNTX-6016 in Healthy Subjects and Subjects With PDNPainful Diabetic NeuropathyUnited States
-
Wakayama Medical UniversityEpidemiological and Clinical Research Information NetworkUnknown
-
AbbVie (prior sponsor, Abbott)CompletedCognitive Deficits in SchizophreniaUnited States
-
Frontera TherapeuticsRecruitingBiallelic RPE65 Mutation-associated Retinal DystrophyChina
-
AstraZenecaCompletedCardiovascular Disease | Healthy Male SubjectsUnited Kingdom
-
NFL Biosciences SASRecruitingSmoking Cessation | Nicotine DependenceFrance
-
Longbio PharmaActive, not recruitingMyelodysplastic Syndrome (MDS)China
-
International AIDS Vaccine InitiativeCoalition for Epidemic Preparedness InnovationsRecruitingLassa FeverGhana, Liberia, Nigeria
-
CinDome Pharma, Inc.CompletedGastroparesisUnited States
-
Iltoo PharmaCompletedSystemic Lupus ErythematosusFrance, Spain, Mexico, Austria, Germany, Bulgaria, Italy, Mauritius, Portugal, Romania
-
AbbVieCompleted
-
Amyndas Pharmaceuticals S.A.CompletedComplement Mediated DiseasesUnited States
-
Rznomics, Inc.RecruitingHepatocellular CarcinomaKorea, Republic of
-
Azura OphthalmicsSyneos Health; Cliantha ResearchCompletedDry Eye | Meibomian Gland DysfunctionCanada, Australia, New Zealand
-
J2H BiotechCompletedNon-alcoholic SteatohepatitisKorea, Republic of
-
Harbour BioMed (Guangzhou) Co. Ltd.RecruitingPrimary Immune Thrombocytopenic PurpuraChina
-
Lynk Pharmaceuticals Co., LtdCompletedAtopic DermatitisChina
-
Lynk Pharmaceuticals Co., LtdCompletedRheumatoid ArthritisChina
-
Israel Institute for Biological Research (IIBR)Completed
-
MedRegen LLCVanderbilt University Medical CenterNot yet recruitingRespiratory Tract Diseases | Respiratory Failure | Acute Respiratory Distress Syndrome | Respiratory Distress Syndrome | Cytokine Storm
-
Sunshine Lake Pharma Co., Ltd.RecruitingProgressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)China
-
Ventyx Biosciences, IncTerminatedPsoriatic ArthritisUnited States, Bulgaria, Czechia, Germany, Hungary, Poland, Spain